2. IV Fluids
Advantage
⢠Preferred route for
administering fluids,
electrolytes and drugs in
emergency
Disadvantage
⢠Drug and solution
incompatibility
⢠Adverse reactions
⢠Infections
⢠Complication
3. Types of IV Fluids
Crystalloids
⢠Solutions with small
molecules that flow
easily from the
bloodstream into the
cells and tissues
⢠E.g.
⢠Isotonic
⢠Hypotonic
⢠hypertonic
Colloids
⢠Act as plasma expanders
⢠Always hypertonic; pulls fluid
from cells into the
bloodstream
⢠Requires close monitoring for
signs and symptoms of
hypervolemia
⢠E.g.
⢠Albumin
⢠Plasma protein fraction
⢠Dextran
4. Types of Fluids according to tonicity
⢠Isotonic solutions
⢠Hypotonic solutions
⢠Hypertonic Solutions
5. Isotonic solutions
⢠Osmolality: 250-300 mOsm/kg
⢠Have a concentration of dissolved particles or
tonicity equal to the intracellular fluid.
⢠Osmotic pressure is therefore the same inside
and outside the cells, so they neither shrink nor
swell with fluid movement.
⢠Eg. D5W/ D5%, PNSS/NS 0.9%, PLR/RL
6. Intravenous Fluids: Isotonic
Solution Uses Special Considerations
D5W/
D5%
Fluid loss
dehydration
- Contraindicated for resuscitation
- caution in renal/ cardiac disease
- doesnât provide enough daily
calories for prolonged use
NS
0.9%
Shock, Hyponatremia,
Resuscitation, BT, DKA,
Hypercalcemia, Metabolic
Alkalosis
- Contraindicated in patientâs with
heart failure, edema,
hypernatremia
RL Dehydration, burn, Lower
GIT fluid loss, acute blood
loss, hypovolemia, mild
metabolic acidosis,
salicylate overdose
- Contraindicated in patients with
renal failure or with liver disease
7. Hypotonic Solutions
⢠Osmolality: < 250 mOsm/kg
⢠Have tonicity less than the ICF, so osmotic
pressure draws water into the cells from the ECF
⢠It makes the cell swell
⢠Ex. Half-normal saline (NS 0.45%), NS 0.33%,
D2.5W /D2.5%
8. Intravenous Fluids: Hypotonic
Solution Uses Special Considerations
0.45%NS
(NaCL
half-
normal
saline),
0.33%
NS,
D2.5%
Water replacement,
DKA after initial NS and
before dextrose solution,
Hypertonic dehydration,
Na and CL depletion,
Gastric fluid loss from
vomiting of NGT lavage
-Use cautiously; can cause
Cardiovascular collapse or
increase ICP
-Contraindicated in patients with
liver disease, trauma or burns
9. Hypertonic Solution
⢠Osmolality: >300mOsm/kg
⢠Tonicity is greater than that of ICF, so osmotic
pressure is unequal inside and outside the cell
⢠It draws fluid from the intracellular space
causing the cells to shrink and extracellular
space to expand.
10. Intravenous Fluids: Hypertonic
Solution Uses Special Considerations
D5NSS
/DNS
Hypotonic dehydration
Temporary treatment of
circulatory insufficiency and
shock if plasma expanders
arenât available
- Contraindicated in patients
with cardiac or renal disease
D10W /
D10%
/D25%
Water replacement
Conditions in which some
nutrition with glucose is
required
Monitor serum glucose
12. Blood Transfusion
⢠Restores blood volume, correct
deficiencies in the bloodâs oxygen
carrying capacity and its coagulation
components, or replace WBC in
patients who need them
⢠Need to be knowledgeable about the various
blood products available to safely transfuse
blood
13. Compatibility
⢠Blood contains various antigens that affect how
compatible one personâs blood is with anotherâs.
⢠The antigen include: ABO blood group, Rh factor
and Human Leukocyte Antigen(HLA) blood group
14. ABOs of typing blood
⢠Identifies two antigens on RBC--- A and B
â A person has both A and B antigens (type AB)
only one antigen (type A or type B)
or neither (type O)
⢠A antigen has anti-B antibodies floating freely in the plasma
⢠B antigen has anti A antibodies floating freely in the plasma
ď§ Type AB â universal recipients
ď§ Type O â universal donors
ď§ Ideally transfusion should be done using the same type of blood as
the patient
16. Rhesus (Rh) factor
⢠About 95% of Indian population in Rh-
positive, which means possessing Rh antigen,
an antigen found on the membrane of RBC
⢠Rh negative people may develop Rh antibody
if exposed to Rh positive blood (Rh
incompatibility)
â 1st exposure: sensitization
â 2nd exposure: fatal hemolytic reaction (can occur
during transfusion or pregnancy)
17. Fixing an Rh problem
⢠If an Rh negative patient is exposed to Rh-
positive blood, an injection of Rh0(D) immune
globulin can be given within 72 hours of
exposure.
⢠Rh0(D) immune globulin inhibits antibody
formation
⢠Common preparation include: Inj. RhoGAM 300,
Inj. Rhoclone 300 (Immunoglobulin)
18. Human Leukocyte Antigen (HLA)
⢠Located on the surface of circulating platelets, WBC
and most tissue cells
⢠Responsible for febrile reactions in patients receiving
a transfusion that contains platelets from several
donors
⢠In that instance antigen-antibody reaction causes
platelet destruction
⢠As a result, patient becomes less responsive to
platelet transfusion
19. Types of Blood products
⢠Fresh Whole blood
ÂťUsed unless the patient has loss more
than 25% of total blood volume.
ÂťUsed to treat hemorrhage, trauma, or
major burns
ÂťShould be avoided if fluid overload is
present
ďźABO compatibility and Rh matching
20. Types of Blood products
⢠Packed RBC
Âť Prepared by removing about 90% of the
plasma surrounding the cells and adding
an anticoagulant preservative
Âť Helps in restoring or maintaining the
oxygen carrying capacity of the blood in
patients with anemic conditions or can
correct blood losses during or after
surgery
Âť ABO compatibility and Rh matching
21. Types of Blood products
⢠WBC
ÂťRarely indicated; however they may be
used to treat gram-negative sepsis or
progressive soft tissue infection thatâs
unresponsive to anti-microbial.
ďź HLA compatibility and Rh matching
22. Types of Blood products
⢠Fresh Frozen Plasma (FFP)
Âť Prepared by separating the plasma from the
RBCs and freezing it within 6 hours of
collection
Âť Used to treat hemorrhage, expand plasma
volume, correct undetermined coagulation
factor deficiencies, replace specific clotting
factors and correct factor deficiencies
resulting from liver disease
ďźRh matching
23. Types of Blood products
⢠Cryoprecipitate (factor VIII)
Âť Insoluble portion of plasma recovered from
FFP
Âť Used to treat hypofibrinogenemia, factor VIII
deficiency (antihemophilic factor),
hemophilia A, DIC
24. Types of Blood products
⢠Albumin
Âť Extracted in plasma and contains globulin
and other proteins
Âť Used for patients who have acute liver
failure, burns, trauma or who have had
surgery as well as for neonates with
hemolytic disease when crystalloids prove
ineffective
25. Types of Blood products
⢠Platelet
Âť Used for patients who have platelet
dysfunction or thrombocytopenia
ďźRh matching
⢠Types:
SDP â Single Donor Platelets
RDP â Random Donor Platelets
26. Blood transfusion procedure
Before starting BT:
ďź Informed consent, explain the procedure
ďź Cultural consideration
ďź VS (if febrile - treat accordingly)
ďź If receiving other medication, it should not be mix with
blood products
ďź Follow Institutional Protocols regarding BT to prevent errors
ďź Triple check the patientâs identity (right transfusion at the right time)
27. How to avoid BT errors
⢠Match the patientâs name, medical record number ABO, Rh
status, blood bank identification numbers with the label on
the blood bag
⢠Check expiration date
⢠Have the other staff to verify the information (Double
check)
⢠Sign the blood slip, filling the required data. The blood slip
will prove useful if the patient develops an adverse effect
⢠Be sure that the blood was cross-matched within the last
48 hours.
28. Blood transfusion procedure
During BT:
ďź Maintain sterile technique
ďź Observe standard precautions
ďź Flush with NS before and after infusing blood products
ďź Infuse blood products through at least an 18G or 20G IV catheter
ďź Transfuse blood using a Y-type IV administration set with filter and
infuse the blood over 2 to 4 hours
ďź When starting the transfusion, remain with the patient and
observe carefully for first 15 minutes
ďź Use a pressure bag or specialized infusion pump to administer
blood more rapidly, if needed
29. ⢠When giving platelet
concentrate, it should be
transfused over 15
minutes
⢠Check platelet count 1
hour after the transfusion
ends
30. Blood transfusion procedure
After BT:
⢠Monitor patientâs status
⢠Watch for signs of fluid overload, especially in elderly patients
⢠Obtain laboratory test
⢠Document:
ďź Patients identification
ďź Identification of blood products, including date of expiration
ďź V.S. before, during and after BT
ďź Date, time, type, amount and duration of transfusion
ďź Adverse reaction and actions taken
ďź Patient response, including laboratory results
ďź Assessment after transfusion
ďź Patient teaching
31. IV Fluids Delivery
methods
⢠Potential IV site:
metacarpal, cephalic,
basilic, median cubital,
greater saphenous
veins
⢠Choose the right site
⢠Needle size: the higher the
size, the smaller the diameter
of the needle
32. Complications of IV therapy
⢠Infiltration
⢠Infection
⢠Phlebitis
⢠Thrombophlebitis
⢠Extravasation
33. Infiltration
⢠Fluid leaks from the vein into surrounding tissue
⢠Occurs when the access device dislodges from the vein
ďźcoolness at the site
ďźpain swelling
ďźleaking
ďźlack of blood return
⢠Management:
ďą Stop the infusion
ďą remove IV catheter
ďą elevate the extremity
ďą apply warm compress
34. Go Small to prevent infiltration
⢠Use the smallest catheter
⢠Avoid placement in joint areas
⢠Anchor the catheter in place
35. Prevention begins with big veins
⢠Remove the IV
⢠Monitor vital signs
⢠Apply warm soaks at the site
⢠Choose large veins and change the catheter
every 72 hours to prevent this complication
36. Infection
⢠The primary barrier to infection is punctured
ďź Purulent drainage at the site
ďź Tenderness
ďź Erythema
ďź Warmth or hardness on palpation
ďź Systemic: fever, chills, inc. WBC
37. Monitoring vital signs is vital
⢠Check vital signs
⢠Swab the site for culture
⢠Remove the catheter
⢠Maintain aseptic technique
38. Phlebitis and thrombophlebitis
⢠Phlebitis is the inflammation of veins
⢠Thrombophlebitis is an irritation of the vein
with the formation of a clot and usually more
painful than phlebitis
ďźpain
ďźredness
ďźSwelling or induration at the site
ďźRed line streaking along the vein
ďźFever
ďźSluggish flow of the solution
39. Extravasation
⢠Similar to infiltration
⢠This results when medications (dopamine,
calcium solutions, and chemo drugs) seep
through veins and produce blistering and
eventually necrosis.
ďźInitially: discomfort and burning sensation at the site
ďźSkin tightness
ďźblanching
ďźLack of blood return
40. Management
⢠Stop the infusions
⢠Apply ice early and warm soaks later
⢠Elevate the extremities
⢠Assess the circulation and nerve function of
the limb
41. Allergic reaction
ďźRed streak extending up the arm
ďźRash
ďźitching
ďźWatery eyes and nose
ďźwheezing
⢠Management
ďą Act Immediately
ďą Stop the IVF immediately
ďą Monitor the patient
ďą Oxygen
ďą Medication â Antihistaminic, Corticosteroid
ďą If Anaphylaxis â Hypovolemia â IV Fluid with Adrenergic Stimulants
(Adrenalin)
42. Air embolism
⢠Occurs when air enters the vein
ďźdecrease in blood pressure
ďźincrease in PR
ďźrespiratory distress
ďźincrease ICP
ďźLoss of consciousness
⢠Management
ďąClamp the IV
ďąPlace the patient on his left side and lower his head
ďąMonitor VS and administer oxygen
ďąTo avoid serious complication, prime all tubing completely,
and tighten all connections securely
43. Speed shock
⢠Occurs when IV solutions or medications are given too
rapidly
ďźFacial flushing
ďźIrregular pulse
ďźSevere headache
ďźDecrease blood pressure
ďźLoss of consciousness and cardiac arrest
⢠Management
ďą clamp the IV immediately
ďą Monitor VS and administer oxygen
ďą Medication â Antihistaminic, Corticosteroids, NSAIDS
ďą Infusion control device can prevent this complication
44. Fluid overload
⢠Happens gradually or suddenly, depending on how well the
patientâs circulatory system can accommodate the fluid.
ďźNeck vein distention
ďźPuffy eyelids
ďźEdema
ďźWeigh gain
ďźIncreased BP
ďźIncreased RR
ďźSOB, cough and crackles
⢠Management
ďąSlow the IV rate and monitor VS
ďąKeep the patient warm, keep the head of bed elevated
ďąGive oxygen and other medication (diuretic)